Leaflet NILOTINIB STADA 150mg capsules
Indicated for: cancer
Route of administration: oral
Substance: nilotinib (tyrosine kinase inhibitor)
ATC: L01EA03 (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors)
This medicine may affect fertility.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
Avoid grapefruit and grapefruit juice.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
This medicine may increase the risk of heart rhythm disturbances.
Nilotinib is a medication used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML). It belongs to the class of tyrosine kinase inhibitors and works by blocking the activity of abnormal proteins that drive cancer cell growth.
The medication is taken orally, usually twice daily on an empty stomach. The dose is adjusted based on the patient's condition and response to treatment. Common side effects include nausea, fatigue, headaches, and skin rashes.
Nilotinib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with cardiac or hepatic conditions.
This medication is an important option for patients with CML, helping to control the disease and improve their quality of life.
General data about NILOTINIB STADA 150mg
- Substance: nilotinib
- Date of latest medicines list: 01-06-2026
- Product code: W70834013
- Concentration: 150mg
- Pharmaceutical form: capsules
- Quantity: 112
- Product type: Generic medicine
- Price: 4569.72 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for nilotinib
- 150mg
- 200mg
- 50mg